[Idiopathic hypercalciuria. Diagnosis and treatment]

Area of Science:

• Nephrology
• Medical Genetics

Background:

• Idiopathic hypercalciuria and calcium nephrolithiasis often have a familial component.
• This metabolic disorder presents with diverse causes and pathogenesis.
• Genetic factors play a significant role in disease development.

Purpose of the Study:

• To systematically review specific gene mutations linked to idiopathic hypercalciuria and nephrolithiasis.
• To explore how identifying these mutations can advance understanding of disease heterogeneity.
• To investigate the potential for personalized patient management based on genetic polymorphisms.

Main Methods:

• Systematic literature review.
• Analysis of genetic mutations associated with idiopathic hypercalciuria.
• Evaluation of treatment strategies for specific genetic variants.

Main Results:

• Specific mutations in idiopathic hypercalciuria and calcium nephrolithiasis were identified.
• Genetic polymorphisms offer insights into the heterogeneous nature of the disease.
• A vitamin D receptor gene mutation shows promise with thiazide diuretics and alendronate.

Conclusions:

• Mutation detection aids in understanding idiopathic hypercalciuria pathogenesis.
• Personalized medicine approaches can be developed based on genetic findings.
• Thiazide diuretics combined with alendronate represent a potential treatment for specific vitamin D receptor gene mutations.